SCHEMBL6422039

SCHEMBL6422039

COC(=O)CN1C(=O)C=C[N]C1=O

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 1/20 0.45
GSK3B P49841 1/20 0.45
KDM4E B2RXH2 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 5/20 0.39
CYP1A2 P05177 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
BLM P54132 1/20 0.39
WRN Q14191 1/20 0.39
HIF1A Q16665 1/20 0.39
POLB P06746 1/20 0.38
CASP3 P42574 3/20 0.38
KAT2B Q92831 1/20 0.36
PPARG P37231 2/20 0.36
HSD17B10 Q99714 1/20 0.35
AKR1B1 P15121 2/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5163732 0.80 GSK3A (0.66) GSK3AGSK3BKDM4ESMN1; SMN2ALDH1A1
SCHEMBL14844624 0.72 MGLL (0.56) GSK3AGSK3BSMN1; SMN2ALDH1A1CYP1A2
SCHEMBL2105111 0.70 P2RX4 (0.40)
SCHEMBL5165436 0.66 KAT2B (0.49) GSK3AGSK3BKDM4ESMN1; SMN2ALDH1A1
SCHEMBL15235653 0.66 POLB (0.47) GSK3AGSK3BKDM4ESMN1; SMN2ALDH1A1
SCHEMBL22152246 0.65 CASP3 (0.48) GSK3AGSK3BKDM4ESMN1; SMN2ALDH1A1
SCHEMBL2754581 0.65 ALDH1A1 (0.49) KDM4ESMN1; SMN2ALDH1A1HPGDPOLB
SCHEMBL25412731 0.63 KAT2B (0.46) KDM4ESMN1; SMN2ALDH1A1BLMWRN
SCHEMBL14086671 0.63 PPARG (0.44) KDM4ESMN1; SMN2ALDH1A1POLBCASP3
SCHEMBL6422034 0.63 KAT2B (0.40) KDM4ESMN1; SMN2ALDH1A1KAT2BPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1605978-A2 THERAPEUTIC COMPOSITIONS Alnylam Pharmaceuticals Inc. (US) 2005-12-21 EP disclosed
WO-2004080406-A2 THERAPEUTIC COMPOSITIONS ALNYLAM PHARMACEUTICALS (US) 2004-09-23 WO disclosed